ClinicalTrials.Veeva

Menu

Applying an Artificial Intelligence-Enabled Electrocardiographic System for Reducing Mortality

N

National Defense Medical Center, Taiwan

Status

Completed

Conditions

Morality
Cardiovascular Diseases
Intensity Care

Treatments

Other: AI-enabled ECG-based Screening Tool

Study type

Interventional

Funder types

Other

Identifiers

NCT05118035
NDMC2021005

Details and patient eligibility

About

This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for early detection of clinical deterioration for reducing mortality.

Enrollment

15,965 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients in emergency department or inpatient department.
  • Patients recieved at least 1 ECG examination.

Exclusion criteria

  • The patients recieved ECG at the period of inactive AI-ECG system.

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

15,965 participants in 2 patient groups

Intervention
Experimental group
Description:
Patients randomized to intervention will have access to the screening tool. Once the AI-ECG indicates high risk of mortality, a warning message would be immediately triggered and sent to the corresponding attending physicians. Notifications appear in the recipient's smartphone message system for the prompt attention. The message notified the physician that, "An ECG was received for patient X. An ECG indicates high risk of mortality. Please intensively attend to patient's conditions. If the physicians need to further identify the ECG, click on the following link to connect the ECG and the result of AI-ECG prediction." Of note, although we will actively send a warning message for high risk cases, the AI-ECG report for low risk cases still presented the degree of risk. Physicians can check the relative severity by access EHR for patients in the intervention group.
Treatment:
Other: AI-enabled ECG-based Screening Tool
Control
No Intervention group
Description:
Patients will continue routine practice.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems